LAACTOBACILLUS REUTERI MM4-1A FOR USE IN THE TREATMENT OR PREVENTION OF AUTISM SPECTRUM DISORDERS

CY1126235T1Undetermined Publication Date: 2026-07-31BAYLOR COLLEGE OF MEDICINE
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CY20231100465T
Authority / Receiving Office
CY · CY
Patent Type
Patents
Current Assignee / Owner
Priority Date
2016-04-15
Filing Date
2023-09-06
Publication Date
2026-07-31
Estimated Expiration
2043-09-06
Patent Text Reader

Abstract

Embodiments of the methods of the disclosure and compositions related to managing the microbiota in an individual having at least one social behavior deficit. In particular embodiments, an individual has at least one social behavior deficit and was born to a mother who was obese, overweight, or consumed a high-fat diet during pregnancy or carries mutations associated with neurodevelopmental behaviors. In particular embodiments, an effective amount of Lactobacillus reuteri is provided to the individual having at least one social behavior deficit to improve at least one symptom of a social behavior deficit.
Need to check novelty before this filing date? Find Prior Art